2.
NSCLC中CHCHD2的表达与临床病理参数的关系
Correlation of the CHCHD2 expression with the clinicopathological characteristics of patients with NSCLC
| Clinical parameters | n | CHCHD2 | expression | P |
| - | + | |||
| Gender | 32 | 28 | ||
| Male | 46 | 25 (54.3%) | 21 (45.7%) | 0.451 |
| Age (year) | ||||
| < 60 | 36 | 20 (55.6%) | 16 (44.4%) | 0.17 |
| Histological type | ||||
| SCC | 40 | 21 (52.5%) | 19 (47.5%) | 0.582 |
| ADC | 20 | 12 (60.0%) | 8 (40.0%) | |
| Grade | ||||
| Well | 22 | 5 (22.7%) | 17 (77.3%) | 0.011 |
| Moderate | 24 | 8 (33.3%) | 16 (66.7%) | |
| Poor | 14 | 10(71.4%) | 4 (28.6%) | |
| TNM stage | ||||
| Ⅰ/Ⅱ | 38 | 24 (63.6%) | 14 (36.8%) | 0.019 |
| Ⅲ/Ⅳ | 22 | 7(31.8%) | 15 (68.2%) | |
| Lymph node metastasis | ||||
| Positive | 36 | 6(16.7%) | 30 (83.3%) | 0.002 |
| Negative | 24 | 11 (45.8%) | 13 (54.2%) | |